LOC440243 Inhibitors
LOC440243 inhibitors encompass a spectrum of chemical compounds that target various signaling pathways and cellular processes, potentially leading to the downregulation of LOC440243's functional activity. Compounds such as Wortmannin and LY294002 exert their inhibitory effects through the blockade of phosphatidylinositol 3-kinase (PI3K), which is essential for the Akt signaling pathway involved in cell survival and proliferation. By inhibiting PI3K, these molecules may indirectly impact LOC440243's activity if it is associated with PI3K/Akt-mediated pathways. Similarly, compounds like Rapamycin, which inhibits mTOR, and PD98059, SB203580, and U0126, which target specific MAPK pathway kinases, could suppress LOC440243 activity by interrupting the pathways crucial for cell growth and stress responses, assuming LOC440243 is involved in these processes.
Further, inhibitors such as SP600125 and Y-27632, which interfere with JNK andROCK signaling respectively, may lead to decreased activity of LOC440243 by modulating apoptosis, cell proliferation, and motility. The proteasome inhibitors Bortezomib and MG132 could impact LOC440243 by altering protein degradation pathways, potentially affecting its stability and turnover if LOC440243 is regulated by proteasomal activity. Additionally, kinase inhibitors like Imatinib and Sorafenib, which target a variety of kinases including BCR-ABL, c-KIT, PDGFR, VEGFR, and Raf, may reduce LOC440243 activity by inhibiting kinases that could be upstream regulators or part of the signaling cascades involving LOC440243. Collectively, these inhibitors provide a diverse toolkit for modulating the activity of LOC440243, offering insights into the intricate regulatory networks that govern its function. Each inhibitor's mechanism of action sheds light on the potential pathways LOC440243 may be involved in, underscoring the complexity of cellular signaling and the nuanced control of protein activities.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of phosphatidylinositol 3-kinase (PI3K), which plays a pivotal role in cell signaling pathways related to growth, proliferation, and survival. By inhibiting PI3K, LOC440243's downstream signaling may be indirectly inhibited, leading to decreased functional activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin specifically binds to FKBP12 and the complex inhibits mTOR (mechanistic target of rapamycin), which is crucial for protein synthesis and cell growth. If LOC440243's activity is linked to mTOR signaling, rapamycin can lead to reduced expression and activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAPK, a kinase that participates in inflammatory responses and stress-induced signaling. Inhibition of p38 MAPK can alter the cellular response to stress, potentially reducing LOC440243 activity if it is stress-responsive. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK1, which is upstream of ERK in the MAPK pathway. If LOC440243 is regulated by ERK signaling, PD98059 can decrease its activity by preventing ERK activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another inhibitor of PI3K, leading to the blockade of Akt phosphorylation and activation, which may decrease cell survival and growth signals that could indirectly affect LOC440243 activity if it is part of these pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, which prevents activation of the ERK pathway. This can lead to downregulation of cellular proliferation signals, potentially impacting LOC440243 if its activity is associated with this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which modulates apoptosis, cell proliferation, and differentiation. By inhibiting JNK, the compound can indirectly influence LOC440243 activity if it is implicated in JNK signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK, which is involved in regulating cell shape, motility, and contraction. Inhibition of ROCK could affect cell dynamics and potentially decrease LOC440243 activity if it plays a role in these processes. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that prevents the degradation of ubiquitinated proteins, leading to cell cycle arrest and apoptosis. If the stability or turnover of LOC440243 is regulated by the ubiquitin-proteasome system, its activity could be impacted. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is another proteasome inhibitor that can induce cell cycle arrest and apoptosis by stabilizing proteins targeted for degradation. Similar to bortezomib, if LOC440243 is regulated by proteasomal degradation, MG132 can influence its activity. | ||||||